Allergan - 25 Year Stock Price History | AGN

Historical daily share price chart and data for Allergan since 1993 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Allergan as of November 16, 2018 is 157.39.
Allergan Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 170.7797 168.1409 193.4600 142.5994 157.3900 -2.54%
2017 215.5207 210.6625 251.0933 161.4871 161.4871 -21.09%
2016 235.5189 299.6087 300.8365 183.6513 204.6406 -32.80%
2015 289.6039 252.5047 330.8198 245.6544 304.5101 21.40%
2014 214.4155 163.7534 263.6912 163.6364 250.8287 53.22%
2013 119.7652 82.0014 163.7046 80.9205 163.7046 95.48%
2012 72.4649 59.0399 88.4673 54.4242 83.7445 42.53%
2011 60.6835 50.1396 70.2090 49.2632 58.7575 16.82%
2010 42.4732 39.2333 50.5875 36.7015 50.2954 30.40%
2009 31.6208 25.6102 39.0678 23.1174 38.5711 49.08%
2008 26.5787 26.1750 30.3233 20.2155 25.8731 -2.10%
2007 28.6519 25.6102 32.8064 24.6170 26.4282 4.26%
2006 26.2634 32.0761 33.8483 20.8582 25.3473 -19.93%
2005 31.2328 31.0634 35.6498 27.3728 31.6574 -0.91%
2004 33.9074 44.1509 47.8220 24.0522 31.9495 -28.67%
2003 36.1605 27.9083 47.5201 26.3113 44.7936 62.72%
2002 25.4444 30.2064 31.9495 18.1317 27.5286 -9.94%
2001 50.1240 47.0430 64.1230 27.1488 30.5667 -38.68%
2000 48.3644 34.0821 67.8915 32.9914 49.8474 42.95%
1999 39.0274 56.4204 57.5792 26.5937 34.8708 -43.05%
1998 43.4178 31.4626 61.2308 29.9435 61.2308 93.83%
1997 23.5824 21.7882 32.7431 15.8822 31.5892 44.37%
1996 19.1365 23.1563 23.9792 12.6590 21.8807 -8.29%
1995 17.7420 12.5373 24.1009 10.2246 23.8574 86.67%
1994 10.4815 11.4418 13.9980 6.3295 12.7808 3.96%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $53.085B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $22.626B 6.93
Mylan (MYL) United Kingdom $18.006B 7.41
Bausch Health Cos (BHC) Canada $8.859B 6.41
Dr Reddy's Laboratories (RDY) India $5.791B 23.13
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.571B 4.29
Supernus Pharmaceuticals (SUPN) United States $2.296B 21.75
Amphastar Pharmaceuticals (AMPH) United States $0.953B 103.35
Akorn (AKRX) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.769B 0.00
Assembly Biosciences (ASMB) United States $0.628B 0.00
CymaBay Therapeutics (CBAY) United States $0.574B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.455B 0.00
Voyager Therapeutics (VYGR) United States $0.405B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.296B 0.00
Teligent (TLGT) United States $0.137B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.093B 0.00
Aevi Genomic Medicine (GNMX) United States $0.071B 0.00
Acasti Pharma (ACST) Canada $0.057B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.051B 0.00
Evoke Pharma (EVOK) United States $0.042B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00